SOTRADECOL™ (sodium tetradecyl sulfate injection) is one of a range of sterile injectable prescription products manufactured by Bioniche Pharma. SOTRADECOL™ is the only FDA-approved, commercially available, sodium tetradecyl sulfate injection in the US market. SOTRADECOL™ is a non-pyrogenic sclerosing agent for IV use only, and is available in two strengths: 1% and 3%, packaged in boxes of
five 2 mL vials.

Produced exclusively by Bioniche Pharma, SOTRADECOL™ is the only sodium tetradecyl sulfate injection (STS) that currently complies with section 505 (j) of the Federal Food, Drug and Cosmetics Act. SOTRADECOL™ is manufactured in our cGMP compliant, FDA approved sterile facility, ensuring long shelf life and sterility.

For further information on SOTRADECOL™ , including its approved indication and possible side effects, please refer to the “Sotradecol Prescribing Information” link above.

For Information on SOTRADECOL™ Reimbursement , please click here.

If you have any clinical question regarding the phlebology practice, the use of sclerosing agents or similar issues, please visit the “American College of Phlebology” website.